Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Current Leases (2021 - 2024)

Historic Current Leases for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $1.7 million.

  • ProQR Therapeutics' Current Leases fell 357.48% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year decrease of 357.48%. This contributed to the annual value of $1.7 million for FY2024, which is 285.63% down from last year.
  • ProQR Therapeutics' Current Leases amounted to $1.7 million in Q4 2024, which was down 357.48% from $1.7 million recorded in Q4 2023.
  • Over the past 5 years, ProQR Therapeutics' Current Leases peaked at $18.6 million during Q2 2021, and registered a low of $18611.0 during Q1 2021.
  • Moreover, its 4-year median value for Current Leases was $14.4 million (2023), whereas its average is $10.3 million.
  • Over the last 5 years, ProQR Therapeutics' Current Leases had its largest YoY gain of 8663067.73% in 2022, and its largest YoY loss of 1970.18% in 2022.
  • Over the past 4 years, ProQR Therapeutics' Current Leases (Quarter) stood at $1.8 million in 2021, then dropped by 19.36% to $1.4 million in 2022, then grew by 22.72% to $1.7 million in 2023, then decreased by 3.57% to $1.7 million in 2024.
  • Its last three reported values are $1.7 million in Q4 2024, $1.7 million for Q4 2023, and $15.8 million during Q3 2023.